Pharmaceutical Technology
September 02, 2011
Peer-Reviewed Research
35
9
The author prepared and analyzed a detailed design of experiments for the manufacture of a simple tablet formulation. The aim was to test whether tablet hardness and weight could be controlled during the compression process by adjusting certain machine parameters.
September 02, 2011
Industry Leaders
35
9
A Q&A with John Plachetka, chair, president, and CEO of POZEN, on recent industry trends.
September 02, 2011
Peer-Reviewed Research
35
9
A new, robust method for protein elution from ceramic hydroxyapatite.
September 02, 2011
Washington Report
35
9
PDUFA renewal legislation sets stage for new policies affecting revenue, resarch, and oversight.
September 02, 2011
Agent-in Place
35
9
Being aware of a forthcoming inspection or how a product was made can make a huge difference.
September 02, 2011
From The Editor
35
9
A report commissioned by FDA evaluates the QbD program.
September 02, 2011
PharmTech Talk
35
9
Internal and external Web-based communities are changing how pharma companies can innovate.
September 02, 2011
Special Feature
35
9
Directors from FDA's Center for Drug Evaluation and Research summarize findings in an FDA-commissioned report on QbD and propose actions the agency can take to encourage full-scale QbD implementation.
September 02, 2011
In the Field
35
9
Growth and change in Brazil and Mexico offer key opportunities for the region's pharmaceutical industry.
September 02, 2011
Outsourcing Outlook
35
9
The EU debt crisis portends of possible negative repercussions for the dose CMO industry.
September 02, 2011
Online Exclusive
35
9
The author offers perspectives on ways in which pharmaceutical companies and other stakeholders in the supply chain can confront the threat of counterfeit products, cargo theft, illegal diversion, and economically motivated adulteration.
September 02, 2011
Packaging Forum
35
9
Smartphones could become the product-authentication tool of choice. Contains online bonus material.
September 02, 2011
Inside ICH
35
9
A summary of the latest steering committee and expert working groups' meeting.
September 02, 2011
Special Report
35
9
Might European officials reverse their position on acceptable production methods?
September 02, 2011
BioForum
35
9
Reauthorization of pediatric exclusivity provisions looms in 2012 and debates begin anew.
September 02, 2011
In the Field
35
9
International Federation of Pharmaceutical Manufacturers and Associations takes global action to improve public health.
September 02, 2011
Special Report
35
9
Industry buy-in is increasing as pharma companies proceed with select projects and research.
September 02, 2011
In the Spotlight
35
9
New product reviews for September 2011 focusing on manufacturing.
September 02, 2011
Pharma Ingredients
35
9
Researchers at MIT and Harvard University report on new methods for producing microscale hydrogels.
September 02, 2011
Viewpoint
35
9
After a series of structural changes, the author wonders whether USP is undergoing an identity crisis. USP CEO Roger L. Williams responds.
September 02, 2011
Special Feature
35
9
The third in a series of eight case studies from the Product Quality Research Institute focuses on facility biocontainment and inactivation.
September 02, 2011
Pharma Ingredients
35
9
Biocatalysis, chemocatalysis, and other chiral technologies continue to attract the investment dollars of CMOs and fine-chemical companies.
September 02, 2011
35
9
Click the title above to open the Pharmaceutical Technology September 2011 issue in an interactive PDF format.